Please log in to determine if you are eligible to purchase PT Programs.
MINIMAL RESIDUAL DISEASE, BCR/ABL1 P210 - MRD
MRD
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
BCR/ABL1 p210 3 Two shipments per year; ships on dry ice

Program Information

  • Three RNA specimens in sterile water
  • For laboratories diagnosing and monitoring leukemia tumor burden by measuring the quantity of BCR/ABL1 fusion transcripts

Shipping Schedule

  • Shipment A: April 23
  • Shipment B: October 8






Customers Who Bought This Item Also Bought
B-ALL MINIMAL RESIDUAL DISEASE
VIEW DETAILS >